Susan G. Komen's ShareForCures | Clinical Trial | StuddyBuddy@endsection Susan G. Komen's ShareForCures
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT05654246

Susan G. Komen's ShareForCures

Conditions: Breast Cancer

Sex: All
Ages: 18 Years – N/A
Enrollment: 200000
Sponsor: Susan G. Komen Breast Cancer Foundation

Location: United States

Summary

ShareForCures (SFC) is a community-based participatory research registry, and its prime objective is to engage participants representative of the United States breast cancer patient population -including minoritized and historically marginalized people, persons, or communities-to ensure the data researchers use to study breast cancer is as diverse as the people touched by this disease. In doing so, researchers will have a better understanding of breast cancer, and everyone can potentially benefit from scientific advances and improvements in care.

Eligibility Criteria

Inclusion Criteria:Individuals must be at least 18 years old. (Individuals in Alabama and Nebraska must be over 19 and individuals in Mississippi and Pennsylvania must be over 21 to participate).Individuals must have been diagnosed with cancer originating (or is suspected to originate) from the breast.Individuals must be currently residing in the United States or a territory of the United States.Individuals must be able to read and understand English.Exclusion Criteria:Individuals under the age of 18 years. (Individuals in Alabama and Nebraska under 19 and individuals in Mississippi and Pennsylvania under 21 are not eligible to participate).Individuals without a diagnosis of breast cancer.Individuals who are not residing in the United States or a territory of the United States.Individuals unable to read and understand English.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05654246). StuddyBuddy aggregates publicly available trial information.